230
Views
30
CrossRef citations to date
0
Altmetric
Original

Family carers and the prevention of heroin overdose deaths: Unmet training need and overlooked intervention opportunity of resuscitation training and supply of naloxone

, , , , , & show all
Pages 211-218 | Published online: 10 Jul 2009
 

Abstract

Aim: To assess (a) carers’ experiences of witnessing overdose; (b) their training needs; and (c) their interest in receiving training in overdose management.

Design: Postal questionnaire distributed through consenting participating local carer group co-ordinators in England.

Sample: 147 carers attending local support groups for friends and families of drug users.

Findings: Carers were usually parents (80%); 89% were currently caring for a heroin user of whom 49% had already had an overdose (93% involving opiates). One third had witnessed heroin being used, and 31 had witnessed an overdose. For eight carers, there had already been a death from drug overdose. There was poor knowledge of how to manage an overdose. Only a quarter had received advice on overdose management (26%) and only one third knew of the opiate antagonist naloxone (33%). The majority (88%) wanted training in overdose management, especially in emergency naloxone administration (88%). Interest in training did not differ according to carer type nor previous overdose experience.

Conclusion: We found evidence of an extensively overlooked carer population, many of whom have already been faced with an overdose situation and yet have received minimal training. We also found high levels of interest in receiving overdose training, in particular, in emergency naloxone administration.

Notes

Notes

[1]  Naloxone is an opiate antagonist drug, given by injection, which rapidly reverses the effects of heroin and other opiates within a few minutes, and which has been used by Accident and Emergency Departments and by some ambulance paramedics for many decades.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.